References
- Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prevent Med 1991;20:47–63
- Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipo-proteins in healthy women. Atherosclerosis 1993;98: 83–90
- Lobo RA. Cardiovascular implications of estrogen replacement therapy. Obstet Gynecol 1990;75 (Suppl):S18–25
- Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc 1998;290:605–13
- Go dsland IF, Walton C, Stevenson JC. Carbo-hydrate metabolism as a cardiovascular disease risk factor — its relation to menopause and hormone replacement therapy. In Samsioe G, ed. Cardio-vascular Disease and HRT: New Perspectives. Carnforth, UK: Parthenon Publishing, 1992:15–22
- Collins P, Beale CM. The Cardioprotective Role of HRT: a Clinical Update. Camforth, UK: Parthenon Publishing, 1996
- Philibert D, Bouchoux F, Degryse M, Lecaque D, Petit F, Gaillard M. The pharmacological profile of a novel norpregnane progestin (trimegestone). Gynecol Endocrinol 1999;13:316–26
- Hunt K, Vessey M. Long-term surveillance of mortality and cancer in women receiving hormonal replacement therapy. BrJ Obstet Gynaecol 1987;94:620–35
- Persson I, Falkeborn M, Lithell H. The effect on myocardial infarction (MI) risk of estrogen and estrogen—progestin combinations. Presented at the Sixth International Congress on the Menopause, Bangkok, Thailand, October 1990:223 (abstr)
- Nachtigall LE, Nachtigall RH, Nachtigall RD, et al. Estrogen replacement therapy. II. A prospec-tive study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1979;54:74–9
- Jacobs DR, Mebane IL, Bangdiwala SI, et al. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics prevalence study. Am J Epidemiol 1990; 131:32–47
- Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from Lipid Research Clinics Program Follow-up Study. Circu-lation 1987;75:1102–9
- Tikkanen MJ. Estrogens, progestins and lipid metabolism. Maturitas 1996;235:551–5
- Gordon T, Kannel WB, Hjordand MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978;89:157–61